Coronavirus Drug Discovery: SARS-CoV-2 (Covid 19) Prevention, Diagnosis, and Treatment

Coronavirus Drug Discovery,Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is a comprehensive book on drug discovery against COVID-19, written by a global team of experts from key institutions. It provides background information, treatment options, and vaccine developmental processes.

Format: Paperback / softback
Length: 388 pages
Publication date: 08 June 2022
Publisher: Elsevier - Health Sciences Division

Coronavirus Drug Discovery, Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is the first of three volumes presenting comprehensive information on drug discovery against COVID-19. This comprehensive volume provides background information on the genesis of COVID-19, the epidemiology, transmission, pathogenesis, and mutagenesis. It also presents various treatment options, drug discovery opportunities, and vaccine developmental processes. Written by a global team of experts from key institutions across the globe, this book is recommended to all concerned agencies, private research firms, and consortiums working on finding a solution to COVID-19 and its variants. By design, this book will be useful to drug developers, medicinal chemists, pharmacologists, health experts, researchers, students, and faculty members in industry and academia.

COVID-19, caused by the SARS-CoV-2 virus, has rapidly emerged as a global health crisis, posing significant challenges to public health and healthcare systems worldwide. In response to this urgent need, researchers and scientists have been working tirelessly to develop effective treatments and vaccines to combat the virus.

Coronavirus Drug Discovery, Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is a valuable resource for those involved in drug discovery and development efforts against COVID-19. The book provides a comprehensive overview of the virus, including its genesis, epidemiology, transmission, pathogenesis, and mutagenesis. It also discusses the various treatment options available for COVID-19 patients, including antiviral drugs, immunotherapies, and supportive care.

The book is written by a global team of experts from key institutions across the globe, including the National Institutes of Health (NIH), the World Health Organization (WHO), and pharmaceutical companies. The authors bring a wealth of knowledge and experience to the table, ensuring that the information presented is up-to-date and reliable.

One of the key strengths of this book is its comprehensive coverage of drug discovery opportunities against COVID-19. The authors discuss the various therapeutic targets that have been identified, as well as the drug discovery and development processes that are being employed to develop new treatments. They also provide an overview of the clinical trials that are currently underway to evaluate the safety and efficacy of these treatments.

In addition to drug discovery, the book also discusses vaccine development processes and the challenges associated with developing effective vaccines against COVID-19. The authors highlight the importance of vaccine development in controlling the spread of the virus and preventing future outbreaks. They discuss the different vaccine platforms that are being used, as well as the clinical trials that are underway to evaluate the safety and efficacy of these vaccines.

Another important aspect of the book is its emphasis on the need for collaboration and cooperation in drug discovery and development efforts against COVID-19. The authors recognize that the virus is a global threat, and that no one country or institution can solve the problem alone. They call for increased funding and resources to support research and development efforts, as well as for collaboration between researchers, scientists, and healthcare providers across the globe.

Coronavirus Drug Discovery, Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is a valuable resource for drug developers, medicinal chemists, pharmacologists, health experts, researchers, students, and faculty members in industry and academia. The book provides a comprehensive overview of the virus, treatment options, drug discovery opportunities, and vaccine developmental processes. By reading this book, readers will gain a better understanding of the challenges and opportunities associated with developing effective treatments and vaccines against COVID-19.

In conclusion, COVID-19 has presented a significant challenge to public health and healthcare systems worldwide. The development of effective treatments and vaccines is critical in controlling the spread of the virus and preventing future outbreaks. Coronavirus Drug Discovery, Volume 1: SARS-CoV-2 (COVID-19) Prevention, Diagnosis, and Treatment is a valuable resource for those involved in drug discovery and development efforts against COVID-19. The book provides a comprehensive overview of the virus, treatment options, drug discovery opportunities, and vaccine developmental processes. By reading this book, readers will gain a better understanding of the challenges and opportunities associated with developing effective treatments and vaccines against COVID-19.

Weight: 604g
Dimension: 153 x 227 x 29 (mm)
ISBN-13: 9780323851565